ClinicalTrials.Veeva

Menu

Femoral frACturEs and COVID-19. (FACE COVID-19)

I

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status

Unknown

Conditions

Femur Fracture
Covid19
Fragility Fracture

Treatments

Other: COVID-19

Study type

Observational

Funder types

Other

Identifiers

NCT04657510
FACE COVID-19

Details and patient eligibility

About

Retrospective cohort study comparing the early prognosis after surgically-treated proximal femur fragility fractures in patients affected and not affected by COVID-19.

Enrollment

140 estimated patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥45 years
  • Admitted to IRCCS Orthopaedic Institute Galeazzi for proximal femur fractures from march 2020 to april 2020.
  • Tested for COVID-19 through naso-pharyngeal swab analized with RT-PCR

Exclusion criteria

  • Age <45 years
  • Not tested for SARS-CoV-2
  • Other fractures (including bilateral proximal femur fractures)

Trial design

140 participants in 2 patient groups

Proximal femur fracture AND COVID-19
Description:
Surgical treatment of femur fracture
Treatment:
Other: COVID-19
Proximal femur fracture NO COVID
Description:
Surgical treatment of femur fracture
Treatment:
Other: COVID-19

Trial contacts and locations

1

Loading...

Central trial contact

Giuseppe M Peretti, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems